Traditional Chinese medicine for treating prostatic hyperplasia

Abstract

The invention discloses a traditional Chinese medicine for treating prostatic hyperplasia, which is prepared from the following traditional Chinese medicines in parts by weight: 5 to 12 parts of radix astragali seu hedysari, 5 to 12 parts of rhizoma rehmanniae praeparata, 5 to 12 parts of Chinese angelica, 5 to 12 parts of squama manis, 5 to 12 parts of hedgehog hide, 6 to 9 parts of sunflower disc, 6 to 9 parts of salty cortex phellodendri, 6 to 9 parts of herba epimedii, 6 to 9 parts of herba lactucae formosanae, 3 to 8 parts of acruginous turmeric rhizome, 3 to 8 parts of coicis semen, 3 to 8 parts of herba ecliptae, 3 to 8 parts of herba balanophorae involucratae, 3 to 8 parts of herba taraxaci, 3 to 7 parts of poria cocos, 3 to 7 parts of salty rhizoma anemarrhenae, 3 to 7 parts of caulis akebiae, 3 to 7 parts of cortex cinnamomi, 3 to 7 parts of herba cistanches, 2 to 5 parts of radix salviae miltiorrhizae, 2 to 5 parts of herba lycopi, 2 to 5 parts of folium artemisiae argyi and 2 to 5 parts of ramulus cinnamomi. The traditional Chinese medicine disclosed by the invention adopts combination of natural traditional Chinese medicines; all medicines are matched mutually and take a synergistic effect; the traditional Chinese medicine has effects of soothing liver and regulating qi, warming the kidney and benefiting qi, removing blood stasis, clearing heat and promoting diuresis and the like, has no toxic or side effects, and has a good curative effect of treating prostatic hyperplasia.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine for treating benign prostatic hyperplasia. Background technique [0002] Prostatic hyperplasia, also known as benign prostatic hyperplasia, also known as prostatic hypertrophy, is a common disease that affects the health of elderly men due to the obvious enlargement of the prostate gland. It is a common cause of urinary retention, urinary system infection and uremia in the elderly. The age of onset is mostly over 50 years old, and the incidence rate is also increasing with age. The pathological changes are mainly prostate tissue and epithelial hyperplasia. The obstruction caused by it in the urinary tract affects urination, directly threatens renal function, and affects the life of patients. cause serious harm to health. At present, finasteride tablets, terazosin capsules and other drugs are mainly used for treatment, but the...

AI Technical Summary

Problems solved by technology

At present, finasteride tablets, terazosin capsules and other drugs are mainly used for treatment, but the above drugs can cause sexual dysfunction, breast enlargement, orthostatic hypotension, syncope, lethargy, peripheral edema, rhinitis, dyspnea and other adverse reactions